Purchase Order 75F40118P99006
- Not listed
- This firm-fixed-price purchase order, valued at $105,243.00, was awarded by the Food and Drug Administration (FDA) within the Department of Health and Human Services (HHS) to Elsevier B.V., doing business as North-Holland (Publishing), for annual access to Elsevier's online eBook collections. Elsevier B.V. is a global information analytics company that predominantly provides the U.S. government with access to its various online databases and platforms, such as ScienceDirect, Scopus, Reaxys,...
- This is a federal contract awarded by the Food and Drug Administration (FDA), a civilian agency, to Elsevier B.V., doing business as North-Holland (Publishing), a global information analytics company. The contract, valued at $3,202,226.57, is for ScienceDirect online subscription services. It is a definitive, firm-fixed-price contract with no set-aside designation. The contract has an ultimate completion date of December 31, 2018 and was awarded on December 31, 2015. Elsevier B.V. has received...
- The Department of Health and Human Services Food and Drug Administration has awarded a firm-fixed price purchase order to Elsevier B.V., doing business as North-Holland (Publishing), for an enterprise-wide site license to access the ScienceDirect online database and platform. The $3,446,570.86 contract has a completion date of December 31, 2021 and was awarded on December 19, 2018. Elsevier is a global information analytics company that provides scientific, technical, and medical content to...
- This is a firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services (HHS), to Elsevier B.V., a global information analytics company doing business as North-Holland (Publishing). The $109,322.00 contract provides the FDA with a web-based subscription to Elsevier's KNOVEL platform, which contains scientific, technical, and medical content, including journals, books, and databases. This contract has no...
- This is a firm-fixed-price delivery order contract awarded to Elsevier B.V., doing business as North-Holland (Publishing), by the Office of the Director at the Department of Health and Human Services (HHS) on September 1, 2024. The contract, valued at $218,444.00, provides the U.S. government with access to Elsevier's various online databases and platforms, such as ScienceDirect, Scopus, Reaxys, and Embase, which contain scholarly literature, patents, chemical substance information, and other...
- This is a $24,542 firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to Elsevier B.V., doing business as North-Holland (Publishing). The contract is for a one-year enterprise-wide license renewal for unlimited user access to Elsevier's scientific, technical, and medical content platforms, including ScienceDirect, Scopus, Reaxys, and Embase. This contract is not...
- This federal contract award was issued by the Office of Logistics and Acquisition Operations, a civilian agency within the U.S. Department of Health and Human Services (HHS). The contract, with a ceiling value of $90,246.98, is for a software subscription and services provided by the prime contractor, Elsevier B.V., doing business as North-Holland (Publishing). The contract is a firm-fixed-price purchase order with no set-aside designation. Elsevier B.V. is a global information analytics company...
- This is a $82,421.32 firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Elsevier B.V., a global information analytics company and subsidiary of Reed International PLC. The contract is for perpetual and annual licenses/access to Elsevier's eBooks and subscriptions to support the FDA's research initiatives. The award has no set-aside designation. Elsevier B.V. has received over $60 million in prime federal contracts, primarily from civilian agencies like the...
- This firm-fixed-price delivery order contract, valued at $301,044.62, was awarded by the U.S. Office of the Director to Elsevier B.V., a global information analytics company, to provide access to ScienceDirect, Scopus, and Embase databases through March 2025. The contract has no set-aside designation. Elsevier B.V., which does business as North-Holland (Publishing), has received over $60 million in prime federal contracts from agencies like the Department of Health and Human Services, Department...
- The U.S. Food and Drug Administration (FDA) awarded a firm-fixed-price purchase order to Elsevier B.V., doing business as North-Holland (Publishing), for perpetual access to the ScienceDirect backfile collections for Cell Press and custom single titles. The contract has a ceiling value of $88,427.00 and a period of performance ending on June 29, 2016. Elsevier B.V. is a global information analytics company that provides scientific, technical, and medical content, including journals, books, and...
This federal contract was awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Elsevier B.V., doing business as North-Holland (Publishing), a global information analytics company. The $302,641.04 firm-fixed-price purchase order is for IT and telecommunications web-based subscription services. The contract has a completion date of March 29, 2023 and was originally awarded on April 13, 2018. Elsevier, as the prime contractor, specializes in providing scientific, technical, and medical content including journals, books, and databases to support biomedical, engineering, and scientific research initiatives across the federal government. The company holds several multi-million dollar indefinite delivery contracts with agencies like the National Institutes of Health and the Library of Congress to provide access to its ScienceDirect, Scopus, Reaxys, and Embase platforms. This contract award is not designated as a set-aside.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Other Administrative Action | $0 | 4/14/22 | |
| P00003 | Exercise an Option | $62.9k | 2/17/21 | |
| P00002 | Exercise an Option | $60.4k | 3/11/20 | |
| P00001 | Exercise an Option | $58.1k | 2/21/19 | |
| Not listed | Not listed | $55.9k | 4/13/18 |